DJT vs GENI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 16, 2026

DJT

54.5
AI Score
VS
GENI Wins

GENI

57.4
AI Score

Investment Advisor Scores

DJT

55score
Recommendation
HOLD

GENI

57score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric DJT GENI Winner
Revenue 3.68M 669.49M GENI
Net Income -712.34M -111.58M GENI
Net Margin -19343.4% -16.7% GENI
Operating Income -573.04M -151.33M GENI
ROE -43.3% -15.4% GENI
ROA -27.1% -9.9% GENI
Total Assets 2.63B 1.13B DJT
Cash 134.56M 280.56M GENI
Current Ratio 1.23 1.56 GENI
Free Cash Flow 14.18M 64.54M GENI

Relative Price Performance (Last 90 Days)

DJT 1M: -37.3% · 3M: -42.7% GENI 1M: -4.9% · 3M: -19.3%

Current Technical Phase

DJT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -16.2%), weak momentum, RSI 34

RSI (14): 34.5 · Price: $4.64

GENI

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -7.8%) with fading momentum, RSI 48

RSI (14): 47.8 · Price: $6.26

Fundamentals Snapshot

Metric DJT GENI
Market Cap — —
Forward P/E 0.0 5.9
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 205.0% 62.3%
Gross Margin 53.0% 29.9%
Operating Margin -20.2% -7.9%
EPS -3.21 -0.61
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, GENI is currently the stronger investment candidate with a higher AI composite score (57.4/100 vs. 54.5/100), supported by its current technical phase (DJT: Markdown, GENI: Distribution) and fundamental profile.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.